Top 5 stories on HIV in Africa from CROI 2023
Top 5 stories on sexual health from CROI 2023
Weight gain on HIV treatment greater in people who start treatment with advanced HIV
Rilpivirine resistance may be barrier to long-acting injectable treatment in South Africa
Rapid adherence testing sheds light on viral suppression and resistance
Lenacapavir plus broadly neutralising antibodies may offer twice-yearly treatment option
Failure of integrase inhibitor-based regimens may be due to a completely novel form of resistance
Weight loss after treatment switch more likely for those with higher body mass
White blood cell changes on islatravir do not lead to a higher risk of infections
